openPR Logo
Press release

Investigation announced for Investors in shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI)

11-29-2022 07:49 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Treace Medical Concepts, Inc. (NASDAQ: TMCI) shares over potential securities laws violations.

An investigation for investors in Treace Medical Concepts, Inc. (NASDAQ: TMCI) shares over potential securities laws violations.

An investigation was announced concerning potential securities laws violations by Treace Medical Concepts, Inc. in connection with certain financial statements.

Investors who purchased shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Treace Medical Concepts, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Ponte Vedra, FL based Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States.

Treace Medical Concepts, Inc. reported that its Total Revenue rose from $57.36 million in 2020 to $94.41 million in 2021, and that its Net Loss increased from $3.66 million in 2020 to $20.55 million in 2021.

On November 15, 2022, Culper Research published a short report on Treace Medical Concepts, Inc. (the "Culper Report"). The Culper Report expressed the "view that Treace's primary innovation has not been in any sort of medical advancements, but in aggressive reimbursement practices and deceptive DTC marketing," which the Culper Report described "as problematic and self-defeating, as insurers appear to have begun placing Lapiplasty procedure reimbursements under scrutiny while customer complaints about misleading claims from Treace are mounting."

Those who purchased shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI) here

News-ID: 2827266 • Views: 323

More Releases from Shareholders Foundation

Investigation announced for Investors in shares of Surmodics, Inc. (NASDAQ: SRDX …
An investigation was announced over potential securities laws violations by Surmodics, Inc. in connection with certain financial statements. Investors who purchased shares of Surmodics, Inc. (NASDAQ: SRDX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Surmodics, Inc. (NASDAQ: SRDX) concerning whether a series of statements
Lawsuit filed for Investors who lost money with shares of Sotera Health Company …
An investor, who purchased shares of Sotera Health Company (NASDAQ: SHC), filed a lawsuit in the U.S. District Court for the Northern District of Ohio over alleged violations of Federal Securities Laws by Sotera Health Company ("Sotera" or the "Company"), certain of the Company's current and former senior executives, members of the Company's Board of Directors, Sotera's private equity shareholders, and the underwriters of the November 20, 2020, initial public
Investors who lost money with shares of Benson Hill, Inc. (NYSE: BHIL) should co …
An investigation was announced for investors of Benson Hill, Inc. (NYSE: BHIL) shares over potential securities laws violations by Benson Hill, Inc. Investors who purchased shares of Benson Hill, Inc. (NYSE: BHIL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Benson Hill, Inc. (NYSE: BHIL regarding its business, its
Deadline coming up in Lawsuit for Investors in The Gap, Inc. (NYSE: GPS) shares
A deadline is coming up on February 3, 2022 in the lawsuit filed for certain investors of The Gap, Inc. (NYSE: GPS) over alleged securities laws violations by The Gap, Inc. Investors who purchased shares of The Gap, Inc. (NYSE: GPS) have certain options and there are strict and short deadlines running. Deadline: February 3, 2022. NYSE: GPS stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for Treace

Hallux Valgus Market Research, Size, and Growth Report | DelveInsight
"Growth of the Hallux Valgus market is expected to be mainly driven by rise in number of prevalent cases, and rise in the usage of current treatment options" The potential drugs recently launched in the Hallux Valgus Market or expected to get launched in the market during the study period 2019-2032 Hallux Valgus Market Research Report is a comprehensive analysis of the study of the Healthcare industry. DelveInsight included in this report